Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-20691.33%
operating margin TTM
-26021.16%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.02 |
| peg ratio | -0.00 |
| price to book ratio | -1.34 |
| price to sales ratio | 7.88 |
| enterprise value multiple | -0.00 |
| price fair value | -1.34 |
profitability ratios | |
|---|---|
| gross profit margin | 60.79% |
| operating profit margin | -26021.16% |
| pretax profit margin | -23770.04% |
| net profit margin | -20691.33% |
| return on assets | -611.14% |
| return on equity | -505.74% |
| return on capital employed | -2857.78% |
liquidity ratio | |
|---|---|
| current ratio | 1.30 |
| quick ratio | 1.30 |
| cash ratio | 0.55 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 1,580.19 |
| cash conversion cycle | -1,580.19 |
| receivables turnover | 0.00 |
| payables turnover | 0.23 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.60 |
| debt equity ratio | -5.47 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 1.22 |
| interest coverage | -4,223.82 |
| cash flow to debt ratio | -11.72 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.88 |
| cash per share | 0.22 |
| operating cash flow per share | -3.88 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -11.72 |
| short term coverage ratios | -11.72 |
| capital expenditure coverage ratio | -74,900.01 |
Frequently Asked Questions
When was the last time Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) reported earnings?
Hepion Pharmaceuticals, Inc. (HEPA) published its most recent earnings results on 14-11-2024.
What is Hepion Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)'s trailing twelve months ROE is -505.74%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Hepion Pharmaceuticals, Inc. (HEPA) currently has a ROA of -611.14%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HEPA's net profit margin stand at?
HEPA reported a profit margin of -20691.33% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HEPA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.30 in the most recent quarter. The quick ratio stood at 1.30, with a Debt/Eq ratio of -5.47.